Advanced Oncotherapy #AVO – UK Assembly and Testing Site Agreement

ADVANCED ONCOTHERAPY PLC  UK assembly and testing site agreement Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that is has signed a lease with the UK Government’s Science and Technology Facilities Council (“STFC”) to establish a UK testing and assembly site for its next generation proton accelerator, “LIGHT”, at the […]

Dad of two claims pioneering treatment in Prague saved his life – Irish Mirror

By the Irish Mirror The 64-year-old, from Kinsale, Co Cork has ‘never looked back’ An engineer who was diagnosed with prostate cancer claims pioneering treatment abroad saved his life. Eamon Jackson flew 1,000 miles to Prague for proton beam therapy and is now free of the disease. Dad-of-two Eamon monitored his PSA levels – a […]

Advanced Oncotherapy #AVO – GPSL Research on Advanced Oncotherapy Plc

       Free to access research and investor meetings in a post-MiFID2 world Advanced Oncotherapy (AVO-GB): Revamped particle therapy story Recommendation: OUTPERFORM (from NON-RATED) Target Price: 155p (from NIL) Current Price: 46p Click here for full PDF version KEY TAKEAWAY We upgrade AVO to OUTPERFORM with a fair value of 155 GBp. The company […]

Advanced Oncotherapy #AVO – Peter Gyllenhammar AB shareholding

TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Advanced Oncotherapy plc 1b. Please indicate if the issuer is […]

Advanced Oncotherapy #AVO – Update on Distribution Agreement

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that discussions between Yantai Cipu, through its affiliated entity Liquid Harmony, and a major medical equipment and pharmaceutical distribution company in China are continuing beyond the previously announced date of 31 March 2018.  As announced on 16 February 2018, Yantai Cipu informed […]

Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy

Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy. Author information  Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States; Department of Radiology, Keio University School of Medicine, Tokyo, Japan. Abstract PURPOSE: To […]

Advanced Oncotherapy #AVO – Hardman & Co Research: Confidence greatly boosted

Confidence greatly boosted: Advanced Oncotherapy (AVO) is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology developed originally at the world-renowned CERN. Major technical milestones were achieved in 2017 and the company remains on track with its development plan. Confidence has been enhanced significantly with integration of the first three structures and […]

Therapeutic particles – CERN Courier

Therapeutic particles by Virginia Greco, CERN. The accelerator technology underpinning Europe’s first particle-therapy facilities, driven by the TERA Foundation during the past 25 years, is poised to unleash new treatment modes in more compact ways. Last September the TERA Foundation – dedicated to the study and development of accelerators for particle therapy – celebrated its 25th […]